ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,061.08
0.08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. I MAB (IMAB) Share Price

IMAB I MAB

1.84
-0.02 (-1.08%)
14 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 I MAB NASDAQ:IMAB NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.02 -1.08 1.84 1.66 3.73 1.86 1.83 1.85 98,437 20:25:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 27.64M -1.47B - N/A 
 Type  Size  Price  Time  Units 
 9 3 1.82 22:58:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IMAB News
06/06/202412:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/06/202412:00PRNUSI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
05/06/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/06/202412:00PRNUSI-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
30/05/202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
23/05/202422:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
23/05/202422:05GLOBEI-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
Period
Draw mode
Data Downloads for IMAB

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest I MAB Articles